Literature DB >> 15652291

Interleukin-10 (IL-10) ameliorates corneal disease in a mouse model of recurrent herpetic keratitis.

Tammie L Keadle1, Patrick M Stuart.   

Abstract

Interleukin 10 (IL-10), a moderator of Delayed Type Hypersensitivity (DTH) responses, has been demonstrated to be present late in acute HSV corneal infection and may help limit blinding inflammatory lesions there. In contrast, IL-10 is present early in the development of recurrent herpetic stromal keratitis (HSK) lesions in mice. To determine the role of IL-10 and DTH responses in recurrent HSK, we examined DTH responses and disease parameters in latently infected IL-10 knock out (KO) mice, and latently infected normal mice that were untreated or received anti-IL-10 antibodies or recombinant IL-10 following ultraviolet-B stimulated ocular HSV recurrence. Low DTH responses were associated with less severe corneal disease while high DTH responses were associated with greater corneal disease. In IL-10 KO mice, and in normal mice given anti-IL-10 antibodies, corneal opacification was increased and DTH responses were significantly prolonged. Normal mice receiving rIL-10 by ocular and intra-peritoneal routes had less severe corneal lesions. Our results indicate that IL-10 and DTH responses play an important role in the pathogenesis of recurrent HSK in mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15652291     DOI: 10.1016/j.micpath.2004.09.003

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  14 in total

1.  Pigment Epithelium-derived Factor secreted by corneal epithelial cells regulates dendritic cell maturation in dry eye disease.

Authors:  Rohan Bir Singh; Tomas Blanco; Sharad K Mittal; Yukako Taketani; Sunil K Chauhan; Yihe Chen; Reza Dana
Journal:  Ocul Surf       Date:  2020-05-06       Impact factor: 5.033

2.  CXCL9 compensates for the absence of CXCL10 during recurrent Herpetic stromal keratitis.

Authors:  Deena Tajfirouz; Devin M West; Xiao-Tang Yin; Chloe A Potter; Robyn Klein; Patrick M Stuart
Journal:  Virology       Date:  2017-03-07       Impact factor: 3.616

3.  Recurrent herpetic stromal keratitis in mice, a model for studying human HSK.

Authors:  Jessica Morris; Patrick M Stuart; Megan Rogge; Chloe Potter; Nipun Gupta; Xiao-Tang Yin
Journal:  J Vis Exp       Date:  2012-12-18       Impact factor: 1.355

4.  A novel p40-independent function of IL-12p35 is required for progression and maintenance of herpes stromal keratitis.

Authors:  Gregory M Frank; Sherrie J Divito; Dawn M Maker; Min Xu; Robert L Hendricks
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-05       Impact factor: 4.799

Review 5.  Corneal lymphangiogenesis in herpetic stromal keratitis.

Authors:  Paul J Park; Michael Chang; Nitin Garg; Jimmy Zhu; Jin-Hong Chang; Deepak Shukla
Journal:  Surv Ophthalmol       Date:  2014-06-10       Impact factor: 6.048

6.  Nona-D-arginine amide suppresses corneal cytokines in Pseudomonas aeruginosa keratitis.

Authors:  Priyanka Karicherla; Siddhesh Aras; Ashok Aiyar; Jeffery A Hobden
Journal:  Cornea       Date:  2010-11       Impact factor: 2.651

7.  A crucial role for B and T lymphocyte attenuator in preventing the development of CD4+ T cell-mediated herpetic stromal keratitis.

Authors:  Likun Xia; Shengnan Zhang; Jiazi Zhou; Yan Li
Journal:  Mol Vis       Date:  2010-10-13       Impact factor: 2.367

8.  Broadening the repertoire of functional herpes simplex virus type 1-specific CD8+ T cells reduces viral reactivation from latency in sensory ganglia.

Authors:  Anthony J St Leger; Sohyun Jeon; Robert L Hendricks
Journal:  J Immunol       Date:  2013-07-22       Impact factor: 5.422

9.  Interferon gamma is not required for recurrent herpetic stromal keratitis.

Authors:  Tammie L Keadle; Diane E Alexander; David A Leib; Patrick M Stuart
Journal:  Virology       Date:  2008-08-27       Impact factor: 3.616

10.  Lornoxicam suppresses recurrent herpetic stromal keratitis through down-regulation of nuclear factor-kappaB: an experimental study in mice.

Authors:  Jie Yin; Zhenping Huang; Yuan Xia; Fei Ma; Li Jing Zhang; Heng Hui Ma; Li Li Wang
Journal:  Mol Vis       Date:  2009-06-14       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.